Published in J Clin Lab Anal on January 01, 1989
Okadaic acid: more than a diarrheic toxin. Mar Drugs (2013) 0.90
Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology (1994) 7.89
The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med (1973) 6.65
A classification of chronic hepatitis. Lancet (1968) 6.07
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Lancet (1977) 2.90
Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol (1984) 2.63
Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet (1970) 2.60
Partial nodular transformation of the liver with portal hypertension. Am J Med (1966) 2.45
Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet (1969) 2.19
The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13
Hereditary spherocytosis with secondary haemochromatosis. Lancet (1968) 2.00
Taxonomy of four marine bacterial strains that produce tetrodotoxin. Int J Syst Bacteriol (1990) 1.91
Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol (1993) 1.84
Hepatitis C virus transmitted by human bite. Lancet (1990) 1.77
8-Hydroxymanzamine A, a beta-carboline alkaloid from a sponge, Pachypellina sp. J Nat Prod (1994) 1.70
Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. Gut (1967) 1.67
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut (1981) 1.67
Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology (1977) 1.65
Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts. J AOAC Int (1995) 1.63
Liver damage due to methotrexate in patients with psoriasis. Br Med J (1971) 1.62
Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis. J Cancer Res Clin Oncol (1986) 1.61
Natural history of hepatitis-associated antigen-positive chronic liver disease. Lancet (1972) 1.59
Arsenic and noncirrhotic portal hypertension. Gastroenterology (1974) 1.57
Palytoxin: a new marine toxin from a coelenterate. Science (1971) 1.56
Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol (1986) 1.55
Liver biopsy in the diagnosis of cirrhosis. Gut (1970) 1.53
Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology (1975) 1.53
Angiosarcoma of the liver: annual occurrence and aetiology in Great Britain. Br J Ind Med (1980) 1.52
Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut (1981) 1.50
Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut (1974) 1.50
Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology (1996) 1.49
The pathology of diabetic hepatitis. J Pathol (1988) 1.48
Hepatic reactions associated with ketoconazole in the United Kingdom. Br Med J (Clin Res Ed) (1987) 1.47
Production of tetrodotoxin and its derivatives by Pseudomonas sp. isolated from the skin of a pufferfish. Toxicon (1987) 1.47
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Immunoglobulin-containing cells in the liver. Clin Exp Immunol (1969) 1.44
Hepatobiliary changes in erythropoietic protoporphyria. Arch Pathol (1965) 1.43
Histological demonstration of copper and copper-associated protein in chronic liver diseases. J Clin Pathol (1978) 1.42
Orcein staining of hepatitis B antigen in paraffin sections of liver biopsies. J Clin Pathol (1975) 1.41
Two analogs of azaspiracid isolated from mussels, Mytilus edulis, involved in human intoxication in Ireland. Nat Toxins (1999) 1.38
The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ (1977) 1.37
Idiopathic acute fatty liver of pregnancy in 12 patients. Q J Med (1982) 1.36
Prognosis of chronic persistent hepatitis. Lancet (1970) 1.35
Ciguatoxin: isolation and chemical nature. Science (1967) 1.35
Presymptomatic Wilson's disease. Lancet (1967) 1.33
The structure elucidation and biological activities of high molecular weight algal toxins: maitotoxin, prymnesins and zooxanthellatoxins. Nat Prod Rep (2000) 1.31
Immunological and histological studies in primary biliary cirrhosis. J Clin Pathol (1970) 1.29
New saxitoxin analogues from the freshwater filamentous cyanobacterium Lyngbya wollei. Nat Toxins (1997) 1.28
Angiosarcoma of the liver in Great Britain, 1963-73. Br Med J (1977) 1.26
Multiple organ damage caused by a new toxin azaspiracid, isolated from mussels produced in Ireland. Toxicon (2000) 1.23
Structures of azaspiracid analogs, azaspiracid-4 and azaspiracid-5, causative toxins of azaspiracid poisoning in Europe. Biosci Biotechnol Biochem (2001) 1.20
Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens. Br Med J (1972) 1.19
Jaundice due to oxyphenisatin. Lancet (1971) 1.19
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut (1994) 1.18
Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship. Biochem J (1992) 1.18
Maitotoxin, a Ca2+ channel activator candidate. J Biol Chem (1982) 1.18
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17
First occurrence of tetrodotoxin in a dendrobatid frog (Colostethus inguinalis), with further reports for the bufonid genus Atelopus. Toxicon (1994) 1.17
A protein phosphatase 2A inhibition assay for a fast and sensitive assessment of okadaic acid contamination in mussels. Toxicon (1996) 1.16
Comparison of oral and intraperitoneal toxicity of yessotoxin towards mice. Toxicon (2002) 1.16
New triterpenoid sulfates from the red alga Tricleocarpa fragilis. J Nat Prod (2000) 1.11
Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology (1991) 1.10
New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J Nat Prod (2001) 1.09
Origins of ciguatera fish poisoning: a new dinoflagellate, Gambierdiscus toxicus Adachi and Fukuyo, definitively involved as a causal agent. Toxicon (1980) 1.09
A new depsipeptide from the sacoglossan mollusk Elysia ornata and the green alga Bryopsis species. J Nat Prod (2000) 1.09
Dinoflagellate Gymnodinium catenatum as the source of paralytic shellfish toxins in Tasmanian shellfish. Toxicon (1987) 1.07
Chronic hepatitis: a problem for the pathologist. Histopathology (1977) 1.07
Electrospray ionization mass spectrometry of tetrodotoxin and its analogs: liquid chromatography/mass spectrometry, tandem mass spectrometry, and liquid chromatography/tandem mass spectrometry. Anal Biochem (2001) 1.07
Aplysiatoxin and debromoaplysiatoxin as the causative agents of a red alga Gracilaria coronopifolia poisoning in Hawaii. Toxicon (1996) 1.06
Diarrhetic shellfish toxin, dinophysistoxin-1, is a potent tumor promoter on mouse skin. Jpn J Cancer Res (1988) 1.06
Some chemical properties of maitotoxin, a putative calcium channel agonist isolated from a marine dinoflagellate. J Biochem (1988) 1.05
Asymptomatic primary biliary cirrhosis. Gut (1973) 1.05
Rifampicin hepatitis. A clinical and histological study. Lancet (1974) 1.05
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology (1986) 1.04
Expression of beta-2-microglobulin on hepatocytes after liver transplantation. Lancet (1985) 1.04
Variation in subcapsular liver structure and its significance in the interpretation of wedge biopsies. J Clin Pathol (1967) 1.04
Is copper hepatotoxic in primary biliary cirrhosis? J Clin Pathol (1981) 1.03
Malyngamides O and P from the sea hare Stylocheilus longicauda. J Nat Prod (2000) 1.03
Progress in the clinical development of new marine-derived anticancer compounds. Anticancer Drugs (2004) 1.02
Ca2+ channel activating function of maitotoxin, the most potent marine toxin known, in clonal rat pheochromocytoma cells. J Biol Chem (1983) 1.02
A giant cystic mesenchymal hamartoma of the liver: diagnosis, management, and study of cyst fluid. Gastroenterology (1983) 1.01
Preparation of monoclonal antibodies against okadaic acid prepared from the sponge Halichondria okadai. Toxicon (1989) 1.01
An immunohistochemical study of the blood vessels within primary hepatocellular tumours. Liver (1992) 1.01
Chemical defenses of the sacoglossan mollusk Elysia rufescens and its host Alga bryopsis sp. J Chem Ecol (2001) 1.01
Portal hypertension in primary biliary cirrhosis. Gut (1971) 1.01
A comparison of transjugular and plugged-percutaneous liver biopsy in patients with impaired coagulation. J Hepatol (1993) 1.00
Studies of GB hepatitis agent in tamarins. Hepatology (1989) 1.00
Oral and intraperitoneal acute toxicity studies of yessotoxin and homoyessotoxins in mice. Toxicon (2003) 1.00
Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator. Br Med J (1979) 1.00
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00
Brevetoxin B4 isolated from greenshell mussels Perna canaliculus, the major toxin involved in neurotoxic shellfish poisoning in New Zealand. Nat Toxins (1999) 0.99
Short-term oral toxicity of homoyessotoxins, yessotoxin and okadaic acid in mice. Toxicon (2004) 0.99
Toxicologic evaluation of yessotoxin. Nat Toxins (1997) 0.99
Tetrodotoxin derivatives in puffer fish. Toxicon (1985) 0.99
Hepatitis A virus replication in tamarins and host immune response in relation to pathogenesis of liver cell damage. J Med Virol (1986) 0.99
The pathology of hepatitis A in man. Liver (1982) 0.99
Adult Niemann-Pick disease: its relationship to the syndrome of the sea-blue histiocyte. Am J Med (1977) 0.99
Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis. Hepatology (1986) 0.98